세계의 술폰아미드 시장 보고서(2025년)

Sulfonamide refers to a group of synthetic antimicrobial agents containing the sulfonamide group, used to treat bacterial infections by inhibiting folic acid synthesis in microbes. These compounds were among the earliest antibiotics developed and remain in use today as part of combination therapies for various infections.

The main product types of sulfonamide include oral sulfonamides, topical sulfonamides, and injectable sulfonamides. Oral sulfonamides are antibiotics that contain the sulfonamide group (-SO2NH2) in their chemical structure. The key chemical structures include sulfanilamide, sulfacetamide, and sulfamethoxazole. Applications include antibacterial, antifungal, antiviral, diuretics, antidiabetic, and others, and they are used by various end users such as hospitals, clinics, research laboratories, and others.

The sulfonamide market research report is one of a series of new reports from The Business Research Company that provides sulfonamide market statistics, including the sulfonamide industry global market size, regional shares, competitors with the sulfonamide market share, detailed sulfonamide market segments, market trends, and opportunities, and any further data you may need to thrive in the sulfonamide industry. This sulfonamide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sulfonamide market size has grown strongly in recent years. It will grow from $2.72 billion in 2024 to $2.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the increasing prevalence of bacterial infections, growing availability of generic sulfonamide drugs, rising cost-effective treatment options, expanded use in veterinary medicine, and the expanding pharmaceutical manufacturing capacity.

The sulfonamide market size is expected to see strong growth in the next few years. It will grow to $3.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for combination therapies, increasing focus on antimicrobial resistance management, expansion of healthcare access in developing regions, growing applications in agriculture and animal husbandry, and supportive regulatory approvals for sulfonamide formulations. Major trends in the forecast period include advancements in drug delivery technologies, innovations in sulfonamide derivatives, development of targeted antibacterial therapies, ongoing research and development in antimicrobial agents, and integration of artificial intelligence in drug discovery.

The growing prevalence of skin infections is expected to drive the expansion of the sulfonamide market. Skin infections, caused by bacteria, viruses, fungi, or parasites invading the skin, lead to symptoms such as redness, swelling, pain, itching, or pus formation. The rise in skin infections is largely due to the increasing presence of antibiotic-resistant bacteria, making common infections more difficult to treat and more likely to spread. Sulfonamides are effective in treating skin infections by inhibiting bacterial growth and disrupting folic acid synthesis, making them effective against various susceptible bacteria. For example, in February 2025, the American Academy of Dermatology, a U.S.-based nonprofit organization, reported that approximately 50 million Americans suffer from acne each year, making it the most common skin condition in the country. As a result, the increasing prevalence of skin infections is fueling the growth of the sulfonamide market.

Companies in the sulfonamide market are focusing on developing innovative therapies, such as those for primary periodic paralysis (PPP), to expand the therapeutic applications of sulfonamide-based drugs and address unmet needs in rare neuromuscular disorders. PPP therapies are designed to manage a group of rare, inherited neuromuscular disorders that cause episodes of muscle weakness or paralysis triggered by changes in blood potassium levels. For example, in May 2024, Cycle Pharmaceuticals Limited, a U.K.-based pharmaceutical company, introduced ORMALVITM (dichlorphenamide) as a therapy option for patients with hypokalemic periodic paralysis (HypoPP), hyperkalemic periodic paralysis (HyperPP), and similar conditions. This FDA-approved therapy provides a specialized treatment for these genetic disorders, characterized by muscle weakness or paralysis linked to fluctuations in potassium levels. A notable feature of this launch is Cycle's patient-centric approach, which focuses on improving accessibility and adherence through tailored support services.

In June 2023, Shionogi & Company Limited, a Japan-based pharmaceutical company, merged with Qpex Biopharma Inc. to accelerate antibiotic research and development, addressing the growing issue of antimicrobial resistance (AMR). This merger allows Shionogi to enhance its expertise in antibiotic research and AMR by combining its strengths with Qpex Biopharma's innovative compounds and networks, speeding up the development of vital pharmaceuticals. Qpex Biopharma Inc. is a U.S.-based company focused on creating novel anti-infective therapies, particularly those targeting drug-resistant infections.

Major players in the sulfonamide market are Abbott Laboratories, Novartis AG, Teva Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Amneal Pharmaceuticals LLC, Lupin Limited, Bimeda Holdings PLC, Fera Science Limited, Virchow Laboratories Limited, Hebei Veyong Bio-Chemical Co. Ltd., Interchemie Werken De Adelaar B.V., AdvaCare Pharma, Manus Aktteva Biopharma LLP, Suleshvari Pharma, Shree Vardayini Chemical Industries Private Limited, VetOne, Zydus Cadila Healthcare Limited, Mission Pharmacal Company, Allegis Pharmaceuticals LLC.

North America was the largest region in the sulfonamide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sulfonamide report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sulfonamide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sulfonamide market consists of sales of sulfamethoxazole, sulfadiazine, furosemide, and thiazide diuretics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sulfonamide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sulfonamide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sulfonamide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sulfonamide market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Oral Sulfonamides; Topical Sulfonamides; Injectable Sulfonamides
• 2) By Chemical Structure: Sulfanilamide; Sulfacetamide; Sulfamethoxazole
• 3) By Application: Antibacterial; Antifungal; Antiviral; Diuretics; Antidiabetic; Other Applications
• 4) By End-User: Hospitals; Clinics; Research Laboratories; Other End Users
• Subsegments:
• 1) By Oral Sulfonamides: Sulfamethoxazole; Sulfisoxazole; Sulfadiazine; Sulfalene
• 2) By Topical Sulfonamides: Sulfacetamide Sodium; Silver Sulfadiazine; Sulfamylon; Sulfadiazine Cream
• 3) By Injectable Sulfonamides: Sulfamethoxazole; Sulfadiazine Sodium; Sulfamethoxypyridazine
• Companies Mentioned: Abbott Laboratories; Novartis AG; Teva Pharmaceutical Industries Limited; Intas Pharmaceuticals Limited; Cadila Pharmaceuticals Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sulfonamide Market Characteristics

3. Sulfonamide Market Trends And Strategies

4. Sulfonamide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sulfonamide Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sulfonamide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sulfonamide Market Growth Rate Analysis
• 5.4. Global Sulfonamide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sulfonamide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sulfonamide Total Addressable Market (TAM)

6. Sulfonamide Market Segmentation

• 6.1. Global Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Sulfonamides
• Topical Sulfonamides
• Injectable Sulfonamides
• 6.2. Global Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfanilamide
• Sulfacetamide
• Sulfamethoxazole
• 6.3. Global Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibacterial
• Antifungal
• Antiviral
• Diuretics
• Antidiabetic
• Other Applications
• 6.4. Global Sulfonamide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Laboratories
• Other End Users
• 6.5. Global Sulfonamide Market, Sub-Segmentation Of Oral Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfamethoxazole
• Sulfisoxazole
• Sulfadiazine
• Sulfalene
• 6.6. Global Sulfonamide Market, Sub-Segmentation Of Topical Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfacetamide Sodium
• Silver Sulfadiazine
• Sulfamylon
• Sulfadiazine Cream
• 6.7. Global Sulfonamide Market, Sub-Segmentation Of Injectable Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfamethoxazole
• Sulfadiazine Sodium
• Sulfamethoxypyridazine

7. Sulfonamide Market Regional And Country Analysis

• 7.1. Global Sulfonamide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sulfonamide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sulfonamide Market

• 8.1. Asia-Pacific Sulfonamide Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sulfonamide Market

• 9.1. China Sulfonamide Market Overview
• 9.2. China Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sulfonamide Market

• 10.1. India Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sulfonamide Market

• 11.1. Japan Sulfonamide Market Overview
• 11.2. Japan Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sulfonamide Market

• 12.1. Australia Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sulfonamide Market

• 13.1. Indonesia Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sulfonamide Market

• 14.1. South Korea Sulfonamide Market Overview
• 14.2. South Korea Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sulfonamide Market

• 15.1. Western Europe Sulfonamide Market Overview
• 15.2. Western Europe Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sulfonamide Market

• 16.1. UK Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sulfonamide Market

• 17.1. Germany Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sulfonamide Market

• 18.1. France Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sulfonamide Market

• 19.1. Italy Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sulfonamide Market

• 20.1. Spain Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sulfonamide Market

• 21.1. Eastern Europe Sulfonamide Market Overview
• 21.2. Eastern Europe Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sulfonamide Market

• 22.1. Russia Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sulfonamide Market

• 23.1. North America Sulfonamide Market Overview
• 23.2. North America Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sulfonamide Market

• 24.1. USA Sulfonamide Market Overview
• 24.2. USA Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sulfonamide Market

• 25.1. Canada Sulfonamide Market Overview
• 25.2. Canada Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sulfonamide Market

• 26.1. South America Sulfonamide Market Overview
• 26.2. South America Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sulfonamide Market

• 27.1. Brazil Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sulfonamide Market

• 28.1. Middle East Sulfonamide Market Overview
• 28.2. Middle East Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sulfonamide Market

• 29.1. Africa Sulfonamide Market Overview
• 29.2. Africa Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sulfonamide Market Competitive Landscape And Company Profiles

• 30.1. Sulfonamide Market Competitive Landscape
• 30.2. Sulfonamide Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Cadila Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

31. Sulfonamide Market Other Major And Innovative Companies

• 31.1. Amneal Pharmaceuticals LLC
• 31.2. Lupin Limited
• 31.3. Bimeda Holdings PLC
• 31.4. Fera Science Limited
• 31.5. Virchow Laboratories Limited
• 31.6. Hebei Veyong Bio-Chemical Co. Ltd.
• 31.7. Interchemie Werken De Adelaar B.V.
• 31.8. AdvaCare Pharma
• 31.9. Manus Aktteva Biopharma LLP
• 31.10. Suleshvari Pharma
• 31.11. Shree Vardayini Chemical Industries Private Limited
• 31.12. VetOne
• 31.13. Zydus Cadila Healthcare Limited
• 31.14. Mission Pharmacal Company
• 31.15. Allegis Pharmaceuticals LLC

32. Global Sulfonamide Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sulfonamide Market

34. Recent Developments In The Sulfonamide Market

35. Sulfonamide Market High Potential Countries, Segments and Strategies

• 35.1 Sulfonamide Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sulfonamide Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sulfonamide Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer